GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
23.99
+1.53 (6.81%)
Nov 21, 2025, 4:00 PM EST
GSK plc Market Cap
GSK plc has a market cap or net worth of $94.43 billion as of November 24, 2025. Its market cap has increased by 32.55% in one year.
Market Cap
94.43B
Enterprise Value
112.83B
Revenue
43.24B
Ranking
n/a
PE Ratio
12.79
Stock Price
$23.99
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has decreased from 96.45B to 94.43B, a decrease of -2.10%. That is a compound annual growth rate of -0.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 94.43B | 37.27% |
| Dec 31, 2024 | 68.79B | -8.64% |
| Dec 29, 2023 | 75.29B | 7.04% |
| Dec 30, 2022 | 70.34B | -35.43% |
| Dec 31, 2021 | 108.95B | 19.45% |
| Dec 31, 2020 | 91.20B | -21.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 555.46M |
| Glass House Brands | 520.88M |
| Tian'an Technology Group | 386.45M |
| CytoDyn | 384.62M |
| Northwest Biotherapeutics | 382.71M |
| American Oncology Network | 346.66M |
| Nika Pharmaceuticals | 311.89M |